Table 1. Baseline Characteristics in Chronic Kidney Disease Participants.
| Non-Dialysis | Dialysis | |
|---|---|---|
| N | 77 | 26 |
| Age, yr | 13.2 (9.5, 16.7) | 18.4 (13.6, 19.3) |
| Male, n (%) | 50 (65) | 15 (58) |
| Race, n (%) | ||
| White | 62 (81) | 12 (46) |
| Black | 14 (18) | 11 (42) |
| Other | 1 (1) | 3 (12) |
| Tanner stage 1-2, n (%) | 35 (46) | 4 (15) |
| Height Z-score | -0.57 ± 1.37 | −1.19 ± 1.15 |
| BMI Z-score | 0.34 ± 1.24 | 0.25 ± 1.39 |
| Underlying renal diagnosis, n (%) | ||
| CAKUT | 52 (68) | 9 (35) |
| Focal segmental glomerulosclerosis | 7 (9) | 12 (46) |
| Systemic Inflammatory | 2 (3) | 1 (4) |
| Other | 16 (20) | 4 (16) |
| Age at CKD diagnosis, yr | 2.5 (birth,8.4) | 8.8 (1.5, 12.9) |
| Interval since CKD diagnosis, yr | 7.1 (5.1,12.1) | 8.5 (3.1,13.6) |
| Hemodialysis, n (%) | 16 (62) | |
| Duration of dialysis, months | 4.5 (1.0, 23.8) | |
| History of prior renal transplantation, n (%) | 14 (54) | |
| History of prior cardiac or liver transplantation, n (%) | 5 (6) | 1 (4) |
Results are presented as mean ± SD, median (interquartile range), or n (%).
CAKUT: Congenital anomalies of the kidney and urinary tract; FSGS: Focal segmental glomerulosclerosis